Trials / Conditions / Metabolic Dysfunction-Associated Steatohepatitis

Metabolic Dysfunction-Associated Steatohepatitis

15 registered clinical trials studyying Metabolic Dysfunction-Associated Steatohepatitis — 11 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-As NCT07462455	Xiamen Amoytop Biotech Co., Ltd.	Phase 1
Recruiting	ECC4703 Food Effect and Relative Bioavailability Study in Healthy Adult Participants NCT07334080	Eccogene	Phase 1
Recruiting	A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase NCT07288138	Eccogene	Phase 2
Recruiting	Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steato NCT06939816	Enyo Pharma	Phase 2
Recruiting	Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial NCT06138821	Pichamol Jirapinyo, MD, MPH	N/A
Enrolling By Invitation	A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change NCT07239167	National Taiwan University Hospital	—
Recruiting	A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Dise NCT06836609	Regeneron Pharmaceuticals	Phase 1
Recruiting	Study of the Link Between MASH ( Metabolic Dysfunction-Associated Steatohepatitis) and MAMs (Mitochondria-Asso NCT06868992	Hospices Civils de Lyon	—
Recruiting	A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH NCT06920043	Boston Pharmaceuticals	Phase 2
Withdrawn	A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis NCT06594523	Sagimet Biosciences Inc.	Phase 3
Withdrawn	A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH NCT06692283	Sagimet Biosciences Inc.	Phase 3
Recruiting	Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH NCT06813508	IRCCS Azienda Ospedaliero-Universitaria di Bologna	—
Recruiting	LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH NCT06632457	Boehringer Ingelheim	Phase 3
Active Not Recruiting	A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017) NCT06465186	Merck Sharp & Dohme LLC	Phase 2
Completed	ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) NCT06342947	Aligos Therapeutics	Phase 2